Clinical Trial Update: Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL)

View source ↗

Summary

A Chilean clinical trial (NIRSE-CL) is evaluating the effectiveness and impact of nirsevimab for respiratory syncytial virus (RSV). The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• BEYFORTUS (Nirsevimab)

Snippet

Sponsor: Instituto Sistemas Complejos de Ingeniería | Conditions: RSV | Status: RECRUITING